BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Job Trends

  Accellent To Shutter Colorado Site, Consolidate Ireland Operations; Will Impact 200 Employees

  September 10, 2014

   · 

  3 min read
• Business

  Afferent Pharmaceuticals Names Kathleen Sereda Glaub As Chief Executive Officer

  September 10, 2014

   · 

  4 min read
• Deals

  Rare Disease Biotech Xenon Pharmaceuticals Inc. Files For $52 Million IPO

  September 10, 2014

   · 

  1 min read
• FDA

  Cohera Medical, Inc.'s TissuGlu® Surgical Adhesive Wins Approval For 18 Month Shelf Life in Europe

  September 10, 2014

   · 

  3 min read
• Business

  Durham’s Liquidia Technologies Inc. Spins Out Second Pharmaceutical Company; Raises $10 Million From Bay Area VC Firm

  September 10, 2014

   · 

  3 min read
• Policy

  Actavis Blood Pressure Pill Not Backed By FDA Advisers

  September 10, 2014

   · 

  5 min read
• Drug Development

  Novartis AG: Rate Of Brain Shrinkage Faster In Multiple Schlerosis Patients

  September 10, 2014

   · 

  12 min read
• Biotech Bay

  We’ll Make Half Our Products In Asia By 2024: Becton, Dickinson and Company COO

  September 10, 2014

   · 

  1 min read
• Pharm Country

  Acorda Therapeutics And HealthCore To Present Real World Health Economics And Outcomes Data On Multiple Sclerosis Therapy AMPYRA

  September 10, 2014

   · 

  1 min read
• Business

  PharmAthene, Inc. Awarded Contract Of Up To $28.1 Million To Develop Next Generation Thermostable Anthrax Vaccine

  September 10, 2014

   · 

  5 min read